Literature DB >> 5305812

Proteinase inhibitors in experimental and clinical pancreatitis.

A G Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5305812     DOI: 10.1111/j.1749-6632.1968.tb20313.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Estimation of plasma esterolytic activity and its in vitro inhibition by proteinase inhibitors during acute pancreatitis in the human.

Authors:  K J Worthington; A Cuschieri
Journal:  Br J Exp Pathol       Date:  1976-04

2.  Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.

Authors:  M Murakawa; T Okamura; T Shibuya; M Harada; T Otsuka; Y Niho
Journal:  Ann Hematol       Date:  1992-05       Impact factor: 3.673

3.  Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.

Authors:  M C Geokas; C Largman; P R Durie; J W Brodrick; S B Ray; M O'Rourke; J Vollmer
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

4.  Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats.

Authors:  C Largman; R D Reidelberger; H Tsukamoto
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

5.  Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.

Authors:  S Sica; L Pagano; P Salutari; A Di Mario; S Rutella; G Leone
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

6.  Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats.

Authors:  J Wisner; D Green; L Ferrell; I Renner
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.